Skip to main content

Advertisement

Correction to: Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs

Article metrics

  • 250 Accesses

The original article was published in BMC Veterinary Research 2019 15:309

Correction to: BMC Vet Res (2019) 15:309

https://doi.org/10.1186/s12917-019-2052-0

The original article [1] contains two mistaken instances of the molecule ‘fipronil’ in the results. These should instead have stated ‘firocoxib’.

Reference

  1. 1.

    de Salazar Alcalá AG, Gioda L, Dehman A, Beugnet F. Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs. BMC Vet Res. 2019;15:309. https://doi.org/10.1186/s12917-019-2052-0.

Download references

Author information

Correspondence to Frederic Beugnet.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

de Salazar Alcalá, A.G., Gioda, L., Dehman, A. et al. Correction to: Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs. BMC Vet Res 15, 347 (2019) doi:10.1186/s12917-019-2116-1

Download citation